News and Information
The pharmaceutical packaging materials industry is on the cusp of a major challenge—how can it respond effectively?
Release date:
2022-12-14
In recent years, as China’s pharmaceutical R&D priorities have shifted from generic drugs to innovative medicines, and as packaging technologies and materials have undergone continuous innovation and iteration,
In recent years, as China’s pharmaceutical R&D has shifted from generic drugs to innovative medicines, and as packaging technologies and materials have continued to evolve, pharmaceutical packaging has likewise transitioned from merely protecting products from contamination to becoming a key source of competitive innovation for drug developers. Looking ahead, there is no doubt that pharmaceutical packaging will offer even greater added value.
As an inseparable component of pharmaceutical products, drug packaging plays a crucial role in ensuring the safety and efficacy of medicines. On June 2, 2022, the National Medical Products Administration published an “Exposure Notice” on its official website, aiming to strengthen regulatory guidance and oversight of the production and quality‑control activities of pharmaceutical packaging material manufacturers.
This standard is known as the NMPA‑issued GMP for pharmaceutical packaging materials, and the pharmaceutical packaging materials industry may soon face a major regulatory challenge. Pharmaceutical packaging material manufacturers must attach great importance to this requirement and enhance the safety, quality reliability, and controllability of their products.
Amid the steadily growing pharmaceutical packaging materials market in China, the material of these packaging products is a critical component of drug quality. Throughout both the research and development and manufacturing phases, all sectors place great emphasis on packaging materials that come into direct contact with pharmaceuticals.
The quality and safety of pharmaceuticals directly affect the public’s health. As an essential component of a drug, packaging plays a critical role in safeguarding product quality after it leaves the factory. To ensure medication safety, pharmaceutical companies must prioritize quality inspection of packaging materials as one of their key tasks. Below, we will examine the relevant aspects of testing pharmaceutical packaging materials.
Looking ahead, Huajian will remain committed to providing society with “safe and effective” pharmaceutical packaging solutions.
Contact Information
Address: No. 7, Jinfeng Road, Wujin Economic Development Zone, Changzhou City, Jiangsu Province
Phone:0519-83888828
Fax: 0519-83888968
Email:sunny@huajianpackage.com
Email:vito@huajianpackage.com
Website Development:China Enterprise Dynamics Changzhou | Tag